Replimune

Replimune’s Pivotal FDA Verdict Approaches as Cash Runway Extends

angelina - February 9, 2026

Replimune Stock at a Crossroads: Insider Sales and Regulatory Hurdles Shape Outlook

kashif hafeez - December 12, 2025